Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for anesthesia in hepatic radiofrequency ablation
ChiCTR2300078192Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- Dec 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, propofol and remifentanil in hepatocellular carcinoma (HCC) (2 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoints: Heart rate, Mean arterial blood pressure and 3 more. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
remimazolampropofolremifentanil
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on ChiCTR2300078192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078192.